F. Leblanc

发表

An Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Regimens in HIV Infection

J. Montaner, M. Gill, L. Lacey, 2012, PharmacoEconomics.

PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.

G. Guyatt, M. Meade, D. Cook, 2004 .

Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.

J. Pellegrin, J. Maugein, F. Leblanc, 1999, The Journal of antimicrobial chemotherapy.

Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996).

M. Nicolas-Chanoine, A. Thabaut, J. Cavallo, 2000, The Journal of antimicrobial chemotherapy.

Mechanisms of beta-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a French multicentre study (1997).

P. Plésiat, G. Couetdic, J. Cavallo, 2002, The Journal of antimicrobial chemotherapy.

[Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].

J. Cavallo, R. Fabre, F. Leblanc, 2000, Pathologie-biologie.

In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.

T. Schaeverbeke, C. Bébéar, H. Renaudin, 1999, The Journal of antimicrobial chemotherapy.

A severe organophosphate poisoning requiring the use of an atropine drip.

B. Benson, F. Leblanc, A. Gilg, 1986, Journal of toxicology. Clinical toxicology.

In Vitro Activity of Grepafloxacin Against Chlamydia trachomatis

C. Bébéar, B. Barbeyrac, F. Leblanc, 1999, Drugs.

Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams

E. Singer, L. Dubreuil, F. Leblanc, 1999, Drugs.

Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996).

M. Nicolas-Chanoine, A. Thabaut, J. Cavallo, 2000, The Journal of antimicrobial chemotherapy.